Asthmapolis is all fired up after getting clearance from the U.S. Food and Drug Administration in early July to market its high-tech asthma-tracking device. ?It?s very, very exciting. There?s a super-positive, wonderful energy around the office every day,? said Inger Couture, chief regulatory officer. The young company, established in 2010 based on the work of co-founder David Van Sickle, an asthma epidemiologist and honorary associate fellow at the UW-Madison, already has moved to bigger quarters at 612 W. Main St. from its previous offices at 3 S. Pinckney St.
Office of Strategic Communication